Recently, Hu et al. reported that it exerts therapeutic effects on obesity-related polycystic ovary syndrome (PCOS) by regulating the kisspeptin-GPR54 pathway and the production of sex hormone-binding globulin (SHBG) (Hu et al., 2025). The gene discussed is SHBG; the disease is obesity due to melanocortin 4 receptor deficiency.